Medicine Ram and Hyman discuss the treatment of hypertensive emergencies [1]. As I read this article several thoughts came to mind. First was the feeling of amazement that it was not so long ago when we approached the problem of a patient with a hypertensive emergency with only one or two alternative means of therapy; and in the final analysis, the treatment was not always uniformly successful.We can look back to the dramatic reversal in the course of the natural history of the disease when we see the remarkable improvement in the fiveyear survival of patients with malignant and accelerated hypertension [2,3]. The Veterans Administration Cooperative Study Group demonstrated the prevention not only of deaths from the progression of disease (as evidenced by the lack of deaths from the manifestations of necrotizing arteriolitis), but also of the cardiovascular complications of hypertension (i.e., congestive heart failure and acute aortic dissection) [4,5]. National health statistics have clearly demonstrated the impressive prevention rates of deaths from acute cerebral vascular incidents; there has been a 48% reduction in the number of deaths from strokes since 1972 [6].The second point that struck me was the tremendous sastisfaction to be derived from the recognition that we are no longer in the position of selecting from one or even a handful of potent, but less than optimal, agents that effectively control arterial pressure (Table 1). A scant decade ago we longed for newer, more effective, more specific, and more potent agents that control arterial pressure with fewer side effects. This wish has now come true so that it is actually possible to tailor antihypertensive drug therapy to suit the hypertensive emergency [7]. We should no longer approach this problem as a question of, &dquo;How do we treat the hypertensive emergency?&dquo; Rather, we can more appropriately ask, &dquo;How do we treat the variety of conditions that constitute the variety of hypertensive emergencies ?&dquo; (See Table 2.)Considerations about the treatment of hypertension have evolved over the past decade [8][9][10]. Initially, we have seen the recommendations from the Joint National Committee to approach the treatment of nonemergent forms of hypertension by a rather straightforward algorithm (i.e., the &dquo;Stepped Care Approach&dquo; for treating patients with essential hypertension). According to this approach all patients were treated initially with a diuretic; other agents were introduced sequentially depending on whether the problem was more increasingly severe, requiring further drug therapy [8]. The most recent report provides several options for the initial treatment of the patient with hypertension [10].